Biomedical subjects

Evgeny Byvatov

Publications and source records attributed to Evgeny Byvatov.

3 recordsLinked to original sources

PubMed2003

Support vector machine applications in bioinformatics.

The support vector machine (SVM) approach represents a data-driven method for solving classification tasks. It has been shown to produce lower prediction error compared to classifiers based on other methods like artificial neural networks, especially when large numbers of features are considered for sample description. In this review, the theory and main principles of the SVM approach are outlined, and successful applications in traditional areas of bioinformatics research are described. Current developments in techniques related to the SVM approach are reviewed which might become relevant for future functional genomics and chemogenomics projects. In a comparative study, we developed neural network and SVM models to identify small organic molecules that potentially modulate the function of G-protein coupled receptors. The SVM system was able to correctly classify approximately 90% of the compounds in a cross-validation study yielding a Matthews correlation coefficient of 0.78. This classifier can be used for fast filtering of compound libraries in virtual screening applications.

Algorithms↗

PubMedDate not supplied

Comparison of support vector machine and artificial neural network systems for drug/nondrug classification.

Support vector machine (SVM) and artificial neural network (ANN) systems were applied to a drug/nondrug classification problem as an example of binary decision problems in early-phase virtual compound filtering and screening. The results indicate that solutions obtained by SVM training seem to be more robust with a smaller standard error compared to ANN training. Generally, the SVM classifier yielded slightly higher prediction accuracy than ANN, irrespective of the type of descriptors used for molecule encoding, the size of the training data sets, and the algorithm employed for neural network training. The performance was compared using various different descriptor sets and descriptor combinations based on the 120 standard Ghose-Crippen fragment descriptors, a wide range of 180 different properties and physicochemical descriptors from the Molecular Operating Environment (MOE) package, and 225 topological pharmacophore (CATS) descriptors. For the complete set of 525 descriptors cross-validated classification by SVM yielded 82% correct predictions (Matthews cc = 0.63), whereas ANN reached 80% correct predictions (Matthews cc = 0.58). Although SVM outperformed the ANN classifiers with regard to overall prediction accuracy, both methods were shown to complement each other, as the sets of true positives, false positives (overprediction), true negatives, and false negatives (underprediction) produced by the two classifiers were not identical. The theory of SVM and ANN training is briefly reviewed.

Algorithms↗

PubMedDate not supplied

SVM-based feature selection for characterization of focused compound collections.

Artificial neural networks, the support vector machine (SVM), and other machine learning methods for the classification of molecules are often considered as a "black box", since the molecular features that are most relevant for a given classifier are usually not presented in a human-interpretable form. We report on an SVM-based algorithm for the selection of relevant molecular features from a trained classifier that might be important for an understanding of ligand-receptor interactions. The original SVM approach was extended to allow for feature selection. The method was applied to characterize focused libraries of enzyme inhibitors. A comparison with classical Kolmogorov-Smirnov (KS)-based feature selection was performed. In most of the applications the SVM method showed sustained classification accuracy, thereby relying on a smaller number of molecular features than KS-based classifiers. In one case both methods produced comparable results. Limiting the calculation of descriptors to only the most relevant ones for a certain biological activity can also be used to speed up high-throughput virtual screening.

Algorithms↗